Klaus Rostgaard
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Multiple Sclerosis Research Studies
- Biochemistry top 1%
- Blood transfusion and management
Papers in
-
- Lymphoma Diagnosis and Treatment 20
- Multiple Sclerosis Research Studies 10
-
- Acute Lymphoblastic Leukemia research 14
- Co-authors
- Henrik Hjalgrim (124 shared papers)Mads Melbye (56 shared papers)Gustaf Edgren (37 shared papers)Nete Munk Nielsen (19 shared papers)Morten Frisch (17 shared papers)Henrik Ullum (39 shared papers)Christian Erikstrup (39 shared papers)Olof Nyrén (19 shared papers)
- Journals
- Transfusion (22 papers)International Journal of Cancer (8 papers)PLoS ONE (8 papers)JNCI Journal of the National Cancer Institute (8 papers)Blood (7 papers)
- Partner nations
- DenmarkSwedenUnited States
In The Last Decade
Klaus Rostgaard
167 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 140
- Pathology and Forensic Medicine 1.4k
- Biochemistry 407
- Genetics 597
- Hematology 636
- Management of Technology and Innovation 411
Countries citing papers authored by Klaus Rostgaard
This map shows the geographic impact of Klaus Rostgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Rostgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Rostgaard more than expected).
Fields of papers citing papers by Klaus Rostgaard
This network shows the impact of papers produced by Klaus Rostgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Rostgaard. The network helps show where Klaus Rostgaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Rostgaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 299 | |
| 2 | [The national patient registry. Evaluation of data quality]. | 1995 | 214 |
| 3 | 2020 | 194 | |
| 4 | 2005 | 193 | |
| 5 | 2010 | 171 | |
| 6 | 2007 | 165 | |
| 7 | 2004 | 134 | |
| 8 | 2007 | 132 | |
| 9 | 2010 | 127 | |
| 10 | 2016 | 123 | |
| 11 | 2005 | 113 | |
| 12 | 2003 | 108 | |
| 13 | 2005 | 107 | |
| 14 | 2010 | 103 | |
| 15 | 2013 | 101 | |
| 16 | 2008 | 99 | |
| 17 | 2003 | 98 | |
| 18 | 2019 | 96 | |
| 19 | 2006 | 96 | |
| 20 | 2015 | 95 |
About Klaus Rostgaard
Klaus Rostgaard is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health, Genetics, Oncology and Management of Technology and Innovation, having authored 175 papers that have together received 6.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Blood donation and transfusion practices (18 papers), Chronic Lymphocytic Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (14 papers), Blood transfusion and management (12 papers), Viral-associated cancers and disorders (11 papers), Multiple Sclerosis Research Studies (10 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.4k citations), Biochemistry (407 citations), Genetics (597 citations), Hematology (636 citations) and Management of Technology and Innovation (411 citations). Klaus Rostgaard has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Henrik Hjalgrim, Mads Melbye, Gustaf Edgren, Nete Munk Nielsen, Morten Frisch, Henrik Ullum, Christian Erikstrup, Olof Nyrén, Ole Birger Pedersen and Tine Westergaard. Their work appears in journals such as Transfusion, International Journal of Cancer, PLoS ONE, JNCI Journal of the National Cancer Institute and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.